About the Retinoblastoma Program
The Retinoblastoma Center of Houston provides multidisciplinary care and innovative treatment for children from around the world.
The Retinoblastoma Center of Houston is a consortium of physicians and scientists from some of the premier medical institutions in Houston: Texas Children’s Cancer Center and Baylor College of Medicine, the Children’s Cancer Hospital at The University of Texas and MD Anderson Cancer Center, and Houston Methodist. We provide comprehensive treatment for children with retinoblastoma; education for patients, families and the medical community; and cutting-edge basic and clinical research.
As the only center of its kind in the Southwestern United States, patients are provided the highest quality of care for their condition. Our team includes specialists in pediatric oncology, ophthalmology, radiation therapy, cell and gene therapy, ocular pathology, cancer genetics and counseling, psychosocial support and a wealth of other services for patients and their families.
Our multidisciplinary approach results in an individualized treatment plan for each patient. We perform genetic testing on every tumor tissue and peripheral blood in all patients who undergo enucleation, and we offer appropriate genetic counseling once we have the testing results.
Depending on the kind and stage of retinoblastoma, the Retinoblastoma Center of Houston offers treatment using ophthalmic surgery, cryosurgery, photocoagulation, proton beam radiation therapy, intrathecal chemotherapy and systemic chemotherapy with or without autologous bone marrow transplant for patients whose disease has spread beyond the eye to other parts of the body. The goal is to use the least invasive treatment necessary to save the child’s life, eye and vision.
At Texas Children’s Cancer Center, retinoblastoma research is currently focused on ocular gene therapy. The Ocular Gene Therapy Group is investigating various gene transfer approaches to treat and prevent eye diseases. It has also developed a novel approach to treating retinoblastoma with the ultimate goal not only of curing the disease, but also saving vision. We are also studying the mechanisms that spread of the disease beyond the eye in children with retinoblastoma with the goal of developing treatments for this debilitating complication of the disease.
Visit the Retinoblastoma Center of Houston’s Website at www.rbhouston.org for more information.